Pfizer Inc. To Keep 100 Workers After Review

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pfizer has confirmed that a change in work practices and an upsurge in workload means it is not going to press ahead with 100 of the 130 redundancies it had flagged one of its Cork plants two years ago.

In 2012, it emerged that the company was planning 130 job losses at its Ringaskiddy facility after one of its biggest-selling drugs, the cholesterol-reducing Lipitor, had come off patent. However, a spokeswoman yesterday confirmed Pfizer had decided not to proceed with 100 of the redundancies.

Help employers find you! Check out all the jobs and post your resume.

Back to news